NO984761L - Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler - Google Patents
Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midlerInfo
- Publication number
- NO984761L NO984761L NO984761A NO984761A NO984761L NO 984761 L NO984761 L NO 984761L NO 984761 A NO984761 A NO 984761A NO 984761 A NO984761 A NO 984761A NO 984761 L NO984761 L NO 984761L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- halogen
- alkoxy
- optionally substituted
- hydrogen
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- OSILBMSORKFRTB-UHFFFAOYSA-N isoquinolin-1-amine Chemical class C1=CC=C2C(N)=NC=CC2=C1 OSILBMSORKFRTB-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical class 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 3
- 125000005936 piperidyl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000005605 benzo group Chemical group 0.000 abstract 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004001 thioalkyl group Chemical group 0.000 abstract 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9607717.7A GB9607717D0 (en) | 1996-04-13 | 1996-04-13 | Pharmaceutically active comounds |
GBGB9608678.0A GB9608678D0 (en) | 1996-04-26 | 1996-04-26 | Pharmaceuticlly active compounds |
GBGB9610892.3A GB9610892D0 (en) | 1996-05-24 | 1996-05-24 | Pharmaceutically active compounds |
PCT/SE1997/000589 WO1997038977A1 (en) | 1996-04-13 | 1997-04-09 | Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984761D0 NO984761D0 (no) | 1998-10-12 |
NO984761L true NO984761L (no) | 1998-12-14 |
Family
ID=27268241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984761A NO984761L (no) | 1996-04-13 | 1998-10-12 | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler |
Country Status (21)
Country | Link |
---|---|
US (1) | US6063789A (cs) |
EP (1) | EP0892784A1 (cs) |
JP (1) | JP2000509028A (cs) |
KR (1) | KR20000005388A (cs) |
CN (1) | CN1221407A (cs) |
AR (1) | AR006619A1 (cs) |
AU (1) | AU706110B2 (cs) |
BR (1) | BR9708607A (cs) |
CA (1) | CA2251681A1 (cs) |
CZ (1) | CZ327698A3 (cs) |
EE (1) | EE9800339A (cs) |
HU (1) | HUP9901739A3 (cs) |
ID (1) | ID16575A (cs) |
IL (1) | IL126476A0 (cs) |
IS (1) | IS4862A (cs) |
NO (1) | NO984761L (cs) |
NZ (1) | NZ331932A (cs) |
PL (1) | PL329308A1 (cs) |
SK (1) | SK134698A3 (cs) |
TR (1) | TR199802060T2 (cs) |
WO (1) | WO1997038977A1 (cs) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011658A1 (en) | 1997-08-29 | 1999-03-11 | Proteus Molecular Design Ltd. | Meta-benzamidine derivatives as serin protease inhibitors |
US6291425B1 (en) | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
AU9298098A (en) * | 1997-09-03 | 1999-03-22 | Guilford Pharmaceuticals Inc. | Amino-substituted compounds, methods, and compositions for inhibiting parp activity |
CN1177835C (zh) | 1998-07-24 | 2004-12-01 | 拜尔公司 | 取代的苯甲酰基环己二酮类化合物 |
IT1302677B1 (it) * | 1998-10-15 | 2000-09-29 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
TW575567B (en) * | 1998-10-23 | 2004-02-11 | Akzo Nobel Nv | Serine protease inhibitor |
SE9901530D0 (sv) * | 1999-04-28 | 1999-04-28 | Astra Pharma Prod | Novel compounds |
DE19920791A1 (de) | 1999-05-06 | 2000-11-09 | Bayer Ag | Substituierte Benzoylisoxazole |
DE19921424A1 (de) | 1999-05-08 | 2000-11-09 | Bayer Ag | Substituierte Benzoylketone |
DE19946853A1 (de) | 1999-09-30 | 2001-04-05 | Bayer Ag | Substituierte Arylketone |
TW591031B (en) * | 2000-02-29 | 2004-06-11 | Takeda Chemical Industries Ltd | Thienopyridine derivatives, their production and use |
US7012098B2 (en) * | 2001-03-23 | 2006-03-14 | Pharmacia Corporation | Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
RU2416603C9 (ru) | 2005-10-25 | 2012-06-20 | Сионоги Энд Ко., Лтд. | Производные аминодигидротиазина |
TW200804290A (en) * | 2005-11-15 | 2008-01-16 | Astrazeneca Ab | Compounds and uses thereof |
US8653067B2 (en) | 2007-04-24 | 2014-02-18 | Shionogi & Co., Ltd. | Pharmaceutical composition for treating Alzheimer's disease |
CA2683887A1 (en) | 2007-04-24 | 2008-11-06 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivatives substituted with a cyclic group having inhibitory activity against production of amyloid beta protein |
CA2727859C (en) | 2008-06-13 | 2016-11-01 | Shionogi & Co., Ltd. | SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY |
WO2010047372A1 (ja) | 2008-10-22 | 2010-04-29 | 塩野義製薬株式会社 | Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体 |
EP2511268B2 (en) | 2009-12-11 | 2021-02-17 | Shionogi & Co., Ltd. | Oxazine derivative |
CN101863900B (zh) * | 2010-06-29 | 2012-07-25 | 天津药物研究院 | 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途 |
JP5766198B2 (ja) | 2010-10-29 | 2015-08-19 | 塩野義製薬株式会社 | 縮合アミノジヒドロピリミジン誘導体 |
JP5816630B2 (ja) | 2010-10-29 | 2015-11-18 | 塩野義製薬株式会社 | ナフチリジン誘導体 |
JPWO2012147763A1 (ja) | 2011-04-26 | 2014-07-28 | 塩野義製薬株式会社 | オキサジン誘導体およびそれを含有するbace1阻害剤 |
US9540359B2 (en) | 2012-10-24 | 2017-01-10 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663550A (en) * | 1968-12-25 | 1972-05-16 | Shionogi & Co | 2-lower alkyl-2,3-dihydrothieno(3,2-c)quinoline oxides |
US3903095A (en) * | 1972-02-18 | 1975-09-02 | Merck & Co Inc | Certain substituted-thieno{8 3,2-c{9 -pyridines |
GB1379111A (en) * | 1972-04-13 | 1975-01-02 | Aspro Nicholas Ltd | Preparation of fused-ring pyridine and pyrazine derivatives |
US4127720A (en) * | 1977-09-21 | 1978-11-28 | Bristol-Myers Company | Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity |
JPH04348326A (ja) * | 1990-07-09 | 1992-12-03 | Sumitomo Electric Ind Ltd | 有機非線形光学材料 |
EP0897912A1 (en) * | 1993-10-21 | 1999-02-24 | G.D. Searle & Co. | Amidino derivatives useful as nitric oxide synthase inhibitors |
-
1997
- 1997-04-09 SK SK1346-98A patent/SK134698A3/sk unknown
- 1997-04-09 CZ CZ983276A patent/CZ327698A3/cs unknown
- 1997-04-09 TR TR1998/02060T patent/TR199802060T2/xx unknown
- 1997-04-09 JP JP9537011A patent/JP2000509028A/ja active Pending
- 1997-04-09 EE EE9800339A patent/EE9800339A/xx unknown
- 1997-04-09 CA CA002251681A patent/CA2251681A1/en not_active Abandoned
- 1997-04-09 WO PCT/SE1997/000589 patent/WO1997038977A1/en not_active Application Discontinuation
- 1997-04-09 PL PL97329308A patent/PL329308A1/xx unknown
- 1997-04-09 CN CN97195337A patent/CN1221407A/zh active Pending
- 1997-04-09 US US08/894,448 patent/US6063789A/en not_active Expired - Fee Related
- 1997-04-09 KR KR1019980708115A patent/KR20000005388A/ko not_active Withdrawn
- 1997-04-09 HU HU9901739A patent/HUP9901739A3/hu unknown
- 1997-04-09 IL IL12647697A patent/IL126476A0/xx unknown
- 1997-04-09 BR BR9708607A patent/BR9708607A/pt unknown
- 1997-04-09 EP EP97918449A patent/EP0892784A1/en not_active Withdrawn
- 1997-04-09 AU AU26550/97A patent/AU706110B2/en not_active Ceased
- 1997-04-09 NZ NZ331932A patent/NZ331932A/en unknown
- 1997-04-11 AR ARP970101464A patent/AR006619A1/es not_active Application Discontinuation
- 1997-04-14 ID IDP971239A patent/ID16575A/id unknown
-
1998
- 1998-10-07 IS IS4862A patent/IS4862A/is unknown
- 1998-10-12 NO NO984761A patent/NO984761L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ID16575A (id) | 1997-10-16 |
HUP9901739A3 (en) | 2000-06-28 |
US6063789A (en) | 2000-05-16 |
CN1221407A (zh) | 1999-06-30 |
JP2000509028A (ja) | 2000-07-18 |
NZ331932A (en) | 2000-02-28 |
CZ327698A3 (cs) | 1999-05-12 |
IL126476A0 (en) | 1999-08-17 |
WO1997038977A1 (en) | 1997-10-23 |
AR006619A1 (es) | 1999-09-08 |
IS4862A (is) | 1998-10-07 |
KR20000005388A (ko) | 2000-01-25 |
EE9800339A (et) | 1999-04-15 |
TR199802060T2 (xx) | 1999-01-18 |
AU706110B2 (en) | 1999-06-10 |
BR9708607A (pt) | 1999-08-03 |
SK134698A3 (en) | 1999-06-11 |
PL329308A1 (en) | 1999-03-15 |
NO984761D0 (no) | 1998-10-12 |
CA2251681A1 (en) | 1997-10-23 |
AU2655097A (en) | 1997-11-07 |
HUP9901739A2 (hu) | 1999-09-28 |
EP0892784A1 (en) | 1999-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984761L (no) | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
NO20064089L (no) | Kondensert ring 4-oksopyrimidinderivat | |
CA2010636A1 (en) | Substituted pyrroles | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
NO20072116L (no) | Farmasoytiske forbindelser | |
ATE353870T1 (de) | Dibenzylaminverbindung und deren medizinische verwendung | |
NO20075059L (no) | Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase | |
EP0656898A1 (en) | PYRIDOPYRIMIDINONE AS AN ACTIVE AGAINST ANGINA. | |
PL373888A1 (en) | 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | |
NO20052038L (no) | Ny adeninforbindelse og anvendelse derav | |
NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
KR950003275A (ko) | 1-벤젠술포닐-1, 3-디히드로-2h-벤즈이미다졸-2-온 유도체 | |
NO20062370L (no) | Amidderivater | |
NO20064400L (no) | Prolin-derivater, og anvendelse av samme som inhibitorer av dipeptidyl peptidase IV | |
NO20062692L (no) | Heterosykliske MEK inhibitorer og fremgangsmater for anvendelse derav | |
NZ595829A (en) | 8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl[1,2,4]triazolo[3,4-f]-1,6-naphthyridine derivatives | |
MY142807A (en) | Benzimidazole derivative and use thereof. | |
EP1679069A4 (en) | NEW PIPERIDINE DERIVATIVE | |
FI942635A0 (fi) | Piperatsiinijohdannaiset 5HT1A-antagonisteina | |
NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20072806L (no) | Aryloksy-substituerte benzimidazolderivater | |
DE3868301D1 (de) | 2-(methyl(4-piperidinyl))-1,2,3,4-tetrahydro-9h-pyrido(3,4-b)indolderivate, ihre herstellung und therapeutische verwendung. | |
NO20072643L (no) | Fenylpiperazinmethanonderivater | |
NO20073283L (no) | Nye pyridotienopyrimidinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |